Is CRO Consolidation Good For Pharma?

Consolidation continues in the CRO space, with the acquisition of Chiltern by LabCorp being just the latest example of top CROs expanding and increasing their breadth of offerings. As large CROs continue to acquire smaller competitors, can sponsor companies expect to benefit from this development? I recently spoke to Andrew Schafer, president of research firm … Continued

CMOs need to increase awareness of offerings, ISR reports

A “new set of leaders” emerged in the contract manufacturing organization (CMO) industry over the past year, though many remain unheard of, according to a recent report. Kate Hammeke, Vice President, Market Research, Industry Standard Research, told us drug product outsourcers are consistent in their prioritization of CMO selection attributes. “The same three attributes topped … Continued

Two-thirds of pharmaceutical manufacturing is outsourced, ISR Reports

Only one-third of manufacturing is currently conducted in-house, from development stages to after commercial launch, according a recent report. The report, published by Industry Standard Research (ISR), explained that the majority of work is outsourced – and mainly to preferred providers, who are netting the largest portion of work. According to Kate Hammeke, Vice President … Continued

Best Practices in Study Feasibility

Successfully navigating the medical, clinical, logistical and regulatory challenges associated with establishing the feasibility of a clinical trial is not easy. Insights from sponsor organizations, CROs and sites have been compiled in ISR’s Best Practices in Study Feasibility report. A particular area of interest for readers of the report are the techniques and innovations proffered … Continued

eTMF market to grow sizably over next three years, ISR reports

The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years. This figure is according to a recent report published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today. … Continued

Clinical Outsourcing Market To See Continued Growth Through 2020

You often hear that this is a good time to be in the pharma industry.  I think that is especially true of the clinical trial sector.  Despite the onslaught of bad press pharma is receiving by both politicians and the general public, advancements in oncology and other serious diseases, coupled with the focus on precision … Continued

When are CMOs used? ISR Reports

While CMOs are currently engaged mainly through tactical outsourcing, this paradigm will shift as more companies begin outsourcing to preferred providers, says ISR report. https://www.outsourcing-pharma.com/Contract-Manufacturing/When-are-CMOs-used-ISR-reports

Orphan drug boom comes with a steady stream of outsourcing

With the FDA approving a record number of orphan drugs in 2014, sponsors weren’t the only ones to reap profits from their development. https://www.outsourcing-pharma.com/Clinical-Development/Orphan-drug-boom-comes-with-a-steady-stream-of-outsourcing

Triangle CROs adopt innovative methods to recruit clinical trial patients

Companies that help pharmaceutical and biotechnology companies conduct clinical trials are increasingly focused on unclogging what can be a major bottleneck – recruiting sufficient numbers of patients willing to test an experimental drug in a reasonable period of time. The stakes are high for these contract research organizations, or CROs – an industry that is … Continued

CRO Market Size: Growth in a Flat R&D World

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: CRO Market Size: Growth in a Flat R&D World https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/CRO-Market-Size-Growth-in-a-Flat-RampD-World/ArticleStandard/Article/detail/834426

ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: ISR Reviews Report “Risk-based Monitoring: Industry Guidance on Adoption, Use, and Outsourcing” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reviews-Report-Risk-based-Monitoring-Industry-/ArticleStandard/Article/detail/816364

What Does the Future Hold for Clinical Monitoring?

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “What Does the Future Hold for Clinical Monitoring?” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=810203

ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “ISR Reports Breaks Down: 2013 Late Phase Market Overview and Outlook” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISR-Reports-Breaks-Down-2013-Late-Phase-Market-Ove/ArticleStandard/Article/detail/807543

Influence of Cost in the CRO Selection Process

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Influence of Cost in the CRO Selection Process” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Influence-of-Cost-in-the-CRO-Selection-Process/ArticleStandard/Article/detail/808507

ISR’s “Social Media: Best Practices and Strategic Use in Patient Recruitment”

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “ISR’s ‘Social Media: Best Practices and Strategic Use in Patient Recruitment’?” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Blogs/ISRs-Social-Media-Best-Practices-and-Strategic-Use/ArticleStandard/Article/detail/802212

Benchmarking Investigator Payments

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Benchmarking Investigator Payments” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=799327

Selection of Phase I Service Providers

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Selection of Phase I Service Providers” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Selection-of-Phase-I-Service-Providers/ArticleStandard/Article/detail/788581

Optimizing Investigator Fees

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Optimizing Investigator Fees” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Data+Analysis/Optimizing-Investigator-Fees/ArticleStandard/Article/detail/800011 I’m not sure if it’s just me, but we still have some work to do on the automatically generated e-mails. I’ve provided DETAILED and SPECIFIC instructions I’d like to see … Continued

Access to patient population more important than price for Phase I outsourcing, says ISR

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Access to patient population more important than price for Phase I outsourcing, says ISR” https://www.outsourcing-pharma.com/Clinical-Development/Access-to-patient-population-more-important-than-price-for-Phase-I-outsourcing-says-ISR

Strong Link Between CRO Service Quality and Financial Performance

ISR’s reports have been featured in numerous industry publications and news sources over the years. Below is a link to Appliedclinicaltrialsonline.com’s: “Strong Link Between CRO Service Quality and Financial Performance” https://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/article/articleDetail.jsp?id=783320

ISR CUSTOMERS